About TeleSkin
TeleSkin is a company based in Esbjerg (Denmark) founded in 2014. TeleSkin has raised $1.47 million across 3 funding rounds from investors including SEED Capital. The company has 1 employees. TeleSkin operates in a competitive market with competitors including Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
- Headquarter Esbjerg, Denmark
- Employees 1
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website teleskin.com
- Social LinkedIn X Facebook
- Legal Name Teleskin Aps
- Net Profit-$12.83 K (USD)11as on Dec 31, 2021
- EBITDA-$12.83 K (USD)11as on Dec 31, 2021
- Total Equity Funding$1.47M (USD)
in 3 rounds
- Latest Funding Round$251.86K (USD), Seed
May 2016
- Investors
- Employee Count1
Funding Insights of TeleSkin
TeleSkin has successfully raised a total of $1.47M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $251.86 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.47M
- Total Rounds 3
- Last Round Seed — $251,861
- First Round $370,082
(Dec 2014)
- Investors Count 1
All 3 funding rounds of TeleSkin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $251,861 | Seed | $3.41M | – | – |
| Mar 2015 | $847,488 | Seed | – | – | |
| Dec 2014 | $370,082 | Seed | $3.14M | – | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2016 | $3.41M | •••••••• |
| Dec 2014 | $3.14M | •••••••• |
Last known valuation $3.41M (May 2016). 1 investors in total: 1 institutional.
Investors in TeleSkin
TeleSkin has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SEED Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backing Nordic tech startups from seed to Series A with investments in Consumer, Deep Tech, and related sectors. | – | seedcapital.dk | - |
Investor details for TeleSkin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of TeleSkin
4 dated milestones of TeleSkin across 2 years, from founding to its latest funding, stage changes and deals.
- Founded TeleSkin is founded.
- Funding First funding round of $370K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $252K.
Competitors of TeleSkin
TeleSkin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| dermasensor.com | 2009 | Miami, United States | $60.75M | 13 | Handheld diagnostic device for skin cancer lesions is developed. | |
| medlumics.com | 2009 | Madrid, Spain | $62.81M | – | Biological tissue imaging is developed using optical coherence tomography. | |
| scibase.com | 1998 | Stockholm, Sweden | $22.3M | – | Point-of-care device for malignant melanoma detection is provided. | |
| skinio.com | 2008 | Chicago, United States | $4.98M | – | Online platform to keep track of skin cancer | |
| amlo-biosciences.com | 2017 | Newcastle Upon Tyne, United Kingdom | $7.69M | 11 | Prognostic tests for early-stage melanoma detection are developed. | |
| skin-analytics.com | 2012 | Salisbury, United Kingdom | $32.61M | 42 | Provider of smartphone based skin cancer detection | |
| skinvision.com | 2011 | Amsterdam, Netherlands | $11M | – | Skin lesions are analyzed via mobile app for melanoma risks. | |
| damae-medical.com | 2014 | Paris, France | $8.98M | – | Non-invasive 3D imaging devices for skin cancer diagnostics are developed. |
Detailed competitors of TeleSkin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Teleskin
Complete news archive for TeleSkin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to TeleSkin
10 companies that operate in the same segment as TeleSkin (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TeleSkin
TeleSkin was founded in 2014.
TeleSkin is headquartered in Esbjerg, Denmark.
TeleSkin is a funded company, having raised a total of $1.47M across 3 funding rounds to date. The company's 1st funding round was a Seed of $370.08K, raised on Dec 2014.
TeleSkin has 1 employees.
TeleSkin was founded in 2014 in Esbjerg, Denmark, as a health technology company. A mobile application is provided to identify atypical moles and monitor changes over time. Awareness of melanoma and other skin diseases is raised through mole tracking features. Premium services allow scans to be compared for detecting alterations. Operations focus on early detection in the dermatology sector.
TeleSkin's top competitors include DermTech, DermaSensor and AMLo Biosciences.
TeleSkin has 1 investor. Key investors include SEED Capital.
The valuation of TeleSkin is $3.41M as of May 2016.
TeleSkin operates through Teleskin Aps.